(Q45882014)

17 December 2017

title

Viral and nonviral factors causing nonspecific replication of tumor- and tissue-specific promoter-dependent oncolytic adenoviruses (English)

1 reference

17 December 2017

1 reference

1 reference

6

Wolfgang Poller

1 reference

17 December 2017

author name string

Almudena Hurtado Picó

1

1 reference

17 December 2017

Xiaomin Wang

2

1 reference

17 December 2017

Isaac Sipo

3

1 reference

17 December 2017

Ulrike Siemetzki

4

1 reference

17 December 2017

Jürgen Eberle

5

1 reference

17 December 2017

Henry Fechner

7

1 reference

17 December 2017

publication date

1 April 2005

1 reference

17 December 2017

published in

Molecular Therapy

1 reference

17 December 2017

volume

11

1 reference

17 December 2017

page(s)

563-577

1 reference

17 December 2017

issue

4

1 reference

17 December 2017

Replicative adenoviruses for cancer therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Adenoviruses with Tcf binding sites in multiple early promoters show enhanced selectivity for tumour cells with constitutive activation of the wnt signalling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Adenoviral vectors with E1A regulated by tumor-specific promoters are selectively cytolytic for breast cancer and melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

A novel attenuated replication-competent adenovirus for melanoma therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Telomerase-dependent oncolytic adenovirus for cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Development of a melanoma-specific adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

A novel tetracycline-controlled transactivator-transrepressor system enables external control of oncolytic adenovirus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Update on adenovirus and its vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Replicative oncolytic adenoviruses in multimodal cancer regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Adenovirus E1A under the control of heterologous promoters: wide variation in E1A expression levels has little effect on virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

The adenovirus type 5 E1A enhancer contains two functionally distinct domains: one is specific for E1A and the other modulates all early units in cis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

New tools for the construction of replication-competent adenoviral vectors with altered E1A regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Promoter trans-activation of protooncogenes c-fos and c-myc, but not c-Ha-ras, by products of adenovirus early region 1A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

The adenoviral transcription factor, E1A 13S, trans-activates the human tumor necrosis factor-alpha promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Adenovirus early region 1A protein activates transcription of a nonviral gene introduced into mammalian cells by infection or transfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Target gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Site-directed mutagenesis by overlap extension using the polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

'Autoreplication' of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

siRNA-mediated gene silencing in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Upstream enhancer activity in the human surfactant protein B gene is mediated by thyroid transcription factor 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.10.021

10.1016/J.YMTHE.2004.10.021

7 January 2021

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

15771959

1 reference

17 December 2017